Ind-Swift Laboratories Limited - Asset Resilience Ratio

Latest as of September 2025: 28.07%

Ind-Swift Laboratories Limited (INDSWFTLAB) has an Asset Resilience Ratio of 28.07% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

Rs4.33 Billion

≈ $46.88 Million USD Cash + Short-term Investments

Total Assets

Rs15.44 Billion

≈ $167.02 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2006–2025)

This chart shows how Ind-Swift Laboratories Limited's Asset Resilience Ratio has changed over time. Check strategic asset allocation of Ind-Swift Laboratories Limited to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Ind-Swift Laboratories Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see INDSWFTLAB market cap overview.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs4.00 Billion	25.89%
Short-term Investments	Rs335.31 Million	2.17%
Total Liquid Assets	Rs4.33 Billion	28.07%

Asset Resilience Insights

Very High Liquidity: Ind-Swift Laboratories Limited maintains exceptional liquid asset reserves at 28.07% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Ind-Swift Laboratories Limited Industry Peers by Asset Resilience Ratio

Compare Ind-Swift Laboratories Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Beijing Sun Novo Pharmaceutical Research Co Ltd SHG:688621	Drug Manufacturers - Specialty & Generic	2.04%
Guizhou Xinbang Pharmaceutical Co Ltd SHE:002390	Drug Manufacturers - Specialty & Generic	0.01%
Guangdong Lifestrong Pharmacy Co. Ltd. SHE:301111	Drug Manufacturers - Specialty & Generic	7.85%
Jw Pharmac KO:001060	Drug Manufacturers - Specialty & Generic	3.65%
Kamada TA:KMDA	Drug Manufacturers - Specialty & Generic	0.00%
Samjin Pharm KO:005500	Drug Manufacturers - Specialty & Generic	0.25%

Annual Asset Resilience Ratio for Ind-Swift Laboratories Limited (2006–2025)

The table below shows the annual Asset Resilience Ratio data for Ind-Swift Laboratories Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-03-31	2.74%	Rs393.66 Million ≈ $4.26 Million	Rs14.38 Billion ≈ $155.55 Million	+2.55pp
2024-03-31	0.19%	Rs27.87 Million ≈ $301.43K	Rs14.60 Billion ≈ $157.94 Million	-0.08pp
2023-03-31	0.27%	Rs49.55 Million ≈ $535.81K	Rs18.24 Billion ≈ $197.27 Million	-0.39pp
2022-03-31	0.66%	Rs118.90 Million ≈ $1.29 Million	Rs18.01 Billion ≈ $194.75 Million	+0.20pp
2021-03-31	0.46%	Rs83.02 Million ≈ $897.84K	Rs18.18 Billion ≈ $196.66 Million	-0.15pp
2020-03-31	0.60%	Rs112.72 Million ≈ $1.22 Million	Rs18.70 Billion ≈ $202.23 Million	-0.33pp
2019-03-31	0.93%	Rs178.74 Million ≈ $1.93 Million	Rs19.24 Billion ≈ $208.07 Million	+1.16pp
2018-03-31	-0.24%	Rs-47.69 Million ≈ $-515.75K	Rs20.23 Billion ≈ $218.78 Million	-1.61pp
2017-03-31	1.37%	Rs293.79 Million ≈ $3.18 Million	Rs21.38 Billion ≈ $231.16 Million	+1.38pp
2015-03-31	-0.01%	Rs-2.15 Million ≈ $-23.21K	Rs22.44 Billion ≈ $242.66 Million	-0.01pp
2013-03-31	0.00%	Rs1.00 Million ≈ $10.81K	Rs23.74 Billion ≈ $256.75 Million	-0.09pp
2012-03-31	0.10%	Rs21.00 Million ≈ $227.11K	Rs22.05 Billion ≈ $238.49 Million	-1.64pp
2011-03-31	1.73%	Rs301.00 Million ≈ $3.26 Million	Rs17.39 Billion ≈ $188.03 Million	+0.34pp
2006-03-31	1.39%	Rs71.60 Million ≈ $774.31K	Rs5.14 Billion ≈ $55.60 Million	--

pp = percentage points

About Ind-Swift Laboratories Limited

NSE:INDSWFTLAB India Drug Manufacturers - Specialty & Generic

Market Cap

$214.71 Million

Rs19.85 Billion INR

Market Cap Rank

#16251 Global

#850 in India

Share Price

Rs228.63

Change (1 day)

+1.94%

52-Week Range

Rs88.15 - Rs246.44

All Time High

Rs246.44